BeOne Medicines
Jan-Henrik Terwey is a seasoned professional in the pharmaceutical industry with extensive experience in medical affairs and clinical development. Currently serving as VP and Head of Medical Affairs for Europe at BeiGene, Jan-Henrik has held significant leadership roles at Atara Biotherapeutics, including VP of Clinical Sciences and Global Development Lead for Allogeneic CAR-T Programs, as well as Global Head of Medical Affairs. Jan-Henrik's earlier career at Amgen included positions as Medical Director for Switzerland and International Development and Therapeutic Area Head for Oncology and Hematology. Training as a resident doctor at Universitätsklinikum Hamburg Eppendorf laid the foundation for Jan-Henrik's expertise. Jan-Henrik Terwey holds a Diploma of Advanced Studies in Pharmaceutical Medicine from the European Center of Pharmaceutical Medicine, complementing academic education received at The University of Göttingen.
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.